Cargando…
Vitiligo in a patient undergoing nivolumab treatment for non–small cell lung cancer
Autores principales: | Kosche, Cory, Mohindra, Nisha, Choi, Jennifer N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232635/ https://www.ncbi.nlm.nih.gov/pubmed/30456282 http://dx.doi.org/10.1016/j.jdcr.2018.08.009 |
Ejemplares similares
-
Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment
por: Furune, Satoshi, et al.
Publicado: (2021) -
Immunotherapy “Shock” with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinoma
por: Zarogoulidis, Paul, et al.
Publicado: (2017) -
Optic Perineuritis Associated with Nivolumab Treatment for Non-Small Cell Lung Cancer
por: Takada, Kenji, et al.
Publicado: (2021) -
A Case of Non-Small Cell Lung Cancer with Possible “Disease Flare” on Nivolumab Treatment
por: Chubachi, Shotaro, et al.
Publicado: (2016) -
Correction to: Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment
por: Furune, Satoshi, et al.
Publicado: (2021)